Orphan-Designation nach Geografischer Verbreitung
- Bacterial lipase
- Bafetinib
- Balsalazide disodium
- Becatecarin
- Beclomethasone 17, 21-dipropionate (oral use)
- Belinostat
- Benzamid, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluormethyl)phenyl]
- Benzoate/phenylacetate
- Benzoic acid, sodium salt
- Beraprost-Natrium
- Beraprost sodium (modified release tablet)
- Beta-artemether / lumefantrin (Pulver zur Herstellung einer Suspension zur Einnahme)
- Betaine anhydrous
- Betulae cortex-Trockenextrakt (DER 0.1-0.2:1), Auszugsmittel: n-Heptan 95 % (V/V)
- Bevacizumab
- Bilayer engineered skin composed of keratinocytes (patient autologous) and fibroblasts (donor allogeneic) in a plasma matrix
- Bimosiamose disodium
- Biotinylated anti-tenascin monoclonal antibody for use with 90-Yttrium
- Blinatumomab
- BLUTGERINNUNGSFAKTOR IX, REKOMBINANT
- Blutgerinnungsfaktor IX vom menschen
- BLUTGERINNUNGSFAKTOR VIII, REKOMBINANT
- Blutgerinnungsfaktor X (Stuart-prower-faktor)
- Bortezomib
- Bosentan
- Bosutinib
- Botulism immune globulin
- Bovine bile extract
- Brivanibalaninat
- Brivaracetam
- Brivudin
- Brostallizin
- Budesonide (oral use)
- Busulfan (Intravenous use)
